Primary Insider Notification

15. Jun 2018 | 1 min read

Bård Sundrehagen, Chief Executive Officer in Gentian Diagnostics AS, has today sold 50,000 Shares in Gentian Diagnostics AS at a price of NOK 50 per share. Following the transaction, the total holding held by Bård Sundrehagen is 307,010 shares.

 

MeldingsID: 453767
UtstederID: GENT-ME
Instrument: GENT-ME
Marked: Merkur Market
Kategori: MELDEPLIKTIG HANDEL FOR PRIMÆRINNSIDERE
Informasjonspliktige opplysninger: Ja

Vedlegg: Primary insider notification Baard Sundrehagen (4)

You may also read


Feb 12, 2026 - Ole Sørlie

Gentian Diagnostics: Key information relating to the proposed cash dividend

Moss, 12 February 2026 The Board of Directors of Gentian Diagnostics ASA proposes a dividend of NOK 0.60 per..

Feb 11, 2026 - Ole Sørlie

Update on the development of the NT-proBNP assay

Gentian Diagnostics ASA announces an update on the development of its NT proBNP assay. Recent investigations..

Feb 11, 2026 - Ole Sørlie

Gentian Diagnostics: Fourth quarter 2025 report

Moss, 11 February 2026 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic..